drugset
drugset / Trial / NCT01305083

Efficacy and Safety Study of Udenafil Tablets in Erectile Dysfunction.

NCT01305083 ↗

Phase 3 Completed 118 enrolled Abdi Ibrahim Ilac San. ve Tic A.S.
RandomizedParallel-groupTriple-blindTreatment

Summary

This randomized, double blind, placebo controlled, multicentric, clinical study will assess the efficacy and safety of Udenafil (100 mg) tablets in patients suffering from erectile dysfunction(ED).

Timeline

Start
2010-10
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Udenafil Small molecule 100 mg —

Indications

erectile dysfunction